Biomarker Center of Excellence
|
The Biomarker Center of Excellence supports your drug development needs by providing a full suite of biomarker assay development and validation services as well as biomarker testing services (both large and small scale) across the drug development continuum, from early proof concept to commercial laboratory testing:
 |
News from the Covance
Biomarker Center of Excellence (BCOE)
NYAS Symposium: Biomarkers and Brain Imaging of Presymptomatic Alzheimer's Disease
The New York Academy of Sciences (NYAS) will be holding an event, Biomarkers and Brain Imaging of Presymptomatic Alzheimer's Disease: Exploring the Silent Years, organized in part by Covance Biomarker Center of Excellence Neuroscience Expert Robert Martone on Tuesday, January 24, 2012.
Want to see previous news? Click here for the news archive.
|
Nonclinical biomarker services:
- Assay development and validation
- Assay and biomarker panels
- Discovery
- Computational Biology
- Genomics
- Proteomics
Clinical biomarker services:
- Full assay portfolio
- Assay development and validation
- Assay production
Biomarker COE Webinar Series
 Learn how the Covance Biomarker Center of Excellence is working to provide you with the most comprehensive and integrated biomarker solutions in the industry.
View More Information
|
|
 |
In the News: Biomarkers & Personalized Medicine
Seeing Biomarkers with the Naked Eye
A new ultra-sensitive and label-free technique to detect molecules has been developed by researchers at Boston University. The technique is based on a resonant scattering phenomena in plasmonic nanohole devices and allows cancer biomarkers to be seen with the naked eye.
[nanotechweb.org]
Lack Of Diagnostics Slows Personalized Medicine
According to the Tufts Center for the Study of Drug Development, many third-party payers are skeptical about the usefulness of certain companion diagnostics and are either denying or restricting test reimbursement.
[Pharmalot]
|
|